Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Hypoxia inducible factor 1α (HIF‐1α), an essential transcriptional factor, is negatively regulated by two different types of oxygen and Fe 2+‐dependent HIF hydroxylases, proline hydroxylase (PHD) and factor inhibiting HIF (FIH), under normoxia. Iron chelators have therefore been used for inducing HIF‐1α expression by inhibiting the hydroxylases. In this study, the iron chelators displayed differential effects for PHD and FIH in cells depending on their iron specificity and membrane permeability rather than their in vitro potencies. The membrane permeability of the strict Fe 2+‐chelator potentially inhibited both hydroxylases, whereas the membrane impermeable one showed no inhibitory effect in cells. In contrast, the depletion of the extracellular Fe 3+ ion was mainly correlated to PHD inhibition, and the membrane permeable one elicited low efficacy for both enzymes in cells. The 3′‐hydroxyl group of quercetin, a natural flavonoid, was critical for inhibition of intracellular hydroxylases. Since the 3′‐methylation of quercetin is induced by catechol‐O‐methyl transferase, the enzyme may regulate the intracellular activity of quercetin. These data suggest that the multiple factors of iron‐chelators may be responsible for regulating the intracellular activity HIF hydroxylases. J. Cell. Biochem. 114: 864–873, 2013. © 2012 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676 · cited 1×
“…Received: 2 May 2012; Manuscript Accepted: 9 October 2012 Accepted manuscript online in Wiley Online Library (wileyonlinelibrary.com): 23 October 2012 DOI 10.1002/jcb.24423 2012 Wiley Periodicals, Inc. under hypoxia [Stolze et al., 2004; Dayan et al., 2006; Pouyssegur et al., 2006].”
BackgroundInfluentialAsparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558 · cited 7×
“The iron chelators, dipyridyl (DP) and desferoxamine (DFO), have been currently used for intracellular HIF-1a stabilization [Lando et al., 2002a; Yeo et al., 2006].”
BackgroundMethodInfluentialLando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550 · cited 3×
“The iron chelators, dipyridyl (DP) and desferoxamine (DFO), have been currently used for intracellular HIF-1a stabilization [Lando et al., 2002a; Yeo et al., 2006].”
BackgroundMethodIvan, M., Haberberger, T., Gervasi, D. C., Michelson, K. S., Günzler, V., Kondo, K., Yang, H., Sorokina, I., Conaway, R. C., Conaway, J. W., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192342099 · Cited by 561 · cited 1×
“Since PHDs and FIH require Fe2þ for their function, ironchelators have been studied as anti-ischemic compounds [Ivan et al., 2002; Tian et al., 2011].”
BackgroundFlavonols, Flavones, Flavanones, and Human Health: Epidemiological Evidence
Graf, B. A., Milbury, P. E., & Blumberg, J. B. (2005) · Journal of Medicinal Food · doi:10.1089/jmf.2005.8.281 · Cited by 556 · cited 1×
“Quercetin (QUE) is the most abundant flavonoid in nature, and provides many beneficial effects protecting cancer, cardiovascular diseases, infections, aging and so on [Graf et al., 2005].”
BackgroundIntracellular iron transport and storage: from molecular mechanisms to health implications
Mackenzie, E. L., Iwasaki, K., & Tsuji, Y. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1893 · Cited by 526 · cited 2×
“Fe2þ is then transported to cytoplasm via divalent metal transporter 1 (DMT1).”
BackgroundKoivunen, P., Hirsilä, M., Günzler, V., Kivirikko, K. I., & Myllyharju, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312254200 · Cited by 447
Dayan, F., Roux, D., Brahimi-Horn, M. C., Pouyssegur, J., & Mazure, N. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4564 · Cited by 294
Specific iron chelators determine the route of ferritin degradation
De Domenico, I., Ward, D. M., & Kaplan, J. (2009) · Blood · doi:10.1182/blood-2009-05-224188 · Cited by 176
Cited by
Broadening horizons: the role of ferroptosis in cancer
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00462-0 · Cited by 2,897
Why cells need iron: a compendium of iron utilisation
Teh, M. R., Armitage, A. E., & Drakesmith, H. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.04.015 · Cited by 114
“Iron chelators and cobalt ions (which displace iron, thereby inactivating PHDs and stabilising HIF1 α ) have historically been used to study hypoxia responses [42,43].”
MethodSalminen, A., Kauppinen, A., & Kaarniranta, K. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1978-z · Cited by 99
“, desferoxamine and 1,10-phenanthrolin, inhibited PHD2 and induced the expression of HIF-1a [62].”
BackgroundLigand Binding of PR-10 Proteins with a Particular Focus on the Bet v 1 Allergen Family
Aglas, L., Soh, W. T., Kraiem, A., Wenger, M., Brandstetter, H., & Ferreira, F. (2020) · Current Allergy and Asthma Reports · doi:10.1007/s11882-020-00918-4 · Cited by 56
Metadata
- Authors
- Cho, E. A., Song, H. K., Lee, S., Chung, B. H., Lim, H. M., & Lee, M. K.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2013-02-18
- Volume
- 114
- Issue
- 4
- Pages
- 864-873
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2139629120
- Cited by
- 37
- References
- 9
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases. https://app.cochat.ai/papers/10.1002/jcb.24423
- The paper
- Cho, E. A., Song, H. K., Lee, S., Chung, B. H., Lim, H. M., & Lee, M. K. (2013). Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.24423
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.